Gene ReportsVolume 25, December 2021, 101341Emergence of the Delta Plus variant of SARS-CoV-2 in IranAuthor links open overlay panelFarid Rahimi a, Amin Talebi Bezmin Abadi bShow moreShareCitehttps://doi.org/10.1016/j.genrep.2021.101341Get rights and contentHighlights•The COVID-19 incidence rose potentially alongside the emergence of the SARS-CoV-2 Delta Plus variant in Iran.•Genomic efforts like that of COG in UK are required in other countries, particularly in low-income and middle-income countries.•National and international mass vaccinations and extant countermeasures are critical for curbing the pandemic.Previous article in issueNext article in issueKeywordsB.1.351/501YV-2B.1.1.7/VUI-202012/12COVID-19MutationK417N mutationPandemicVaccineDelta plus SARS-CoV-2 variantRecommended articlesCited by (0)View Abstract© 2021 Elsevier Inc. All rights reserved.
